YevgeniyKharitonMDMSC

Heart Failure & Transplantation

General Cardiology Fellow

Dr. Khariton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2016
University of Missouri Kansas City School of MedicineClass of 2013

TX State Medical License 2022 - 2025
MO State Medical License 2016 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

PubMed

298 citations
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug, Dalane W. Kitzman, Sanjiv J. Shah
Nature Medicine. 2021-10-28
18 citations
Impact of Telemonitoring on Health Status.
Natalie Jayaram, Yevgeniy Khariton, Harlan M. Krumholz, Sarwat I. Chaudhry, Jennifer A. Mattera
Circulation. Cardiovascular Quality and Outcomes. 2017-12-01
72 citations
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.
Yevgeniy Khariton, Michael E. Nassif, Laine Thomas, Gregg C. Fonarow, Xiaojuan Mi
JACC. Heart Failure. 2018-06-01

Sacubitril/valsartan Improves Short-Term Health Outcomes in Those with HFrEFNovember 1st, 2019
Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy: State-of-the-Art Review and an Updated Analysis from UNOS (JACC Heart Failure November 2023)November 5th, 2023